BioLineRx (BLRX) will change the number of ordinary shares represented by American depositary shares to 600 shares per ADS from 15.
The change in the exchange ratio will have the same effect as a 1-for-40 reverse stock split of the ADSs, lowering the number of outstanding ADSs to 3.56 million from 142.3 million, the company said Friday in a statement.
The new ratio will take effect before the start of trading on the Nasdaq on Thursday.
Price: 0.10, Change: -0.02, Percent Change: -17.80
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.